Items without sitelinks
Jump to navigation
Jump to search
Showing below up to 50 results in range #1,451 to #1,500.
- lactate aldolase activity (Q20950)
- formylaspartate deformylase activity (Q20949)
- 2-hydroxyacyl-CoA lyase activity (Q20948)
- 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity (Q20947)
- oxalyl-CoA decarboxylase activity (Q20946)
- formyl-CoA(4-) (Q20945)
- formyl-CoA hydrolase activity (Q20944)
- formyl phosphate(2-) (Q20943)
- formate kinase activity (Q20942)
- formate dehydrogenase (NADP+) activity (Q20941)
- oxidation number (Q20940)
- neurotoxin (Q20939)
- respiratory arrest (Q20938)
- tachycardia (Q20937)
- rhabdomyolysis (Q20936)
- chronic renal disease (Q20935)
- impaired renal function disease (Q20934)
- kidney failure (Q20933)
- osmoregulation (Q20932)
- electrolyte imbalance (Q20931)
- eye pain (Q20930)
- acid–base homeostasis (Q20929)
- abnormality (Q20928)
- acid–base imbalance (Q20927)
- pH of blood (Q20926)
- acidosis (Q20925)
- metabolic acidosis (Q20924)
- physiological absorption (Q20923)
- skin absorption (Q20922)
- restlessness (Q20920)
- psychomotor agitation (Q20919)
- mania (Q20918)
- Mallet-Guy's sign (Q20917)
- pancreatitis (Q20916)
- pupil symptom (Q20915)
- dilated pupil (Q20914)
- mydriasis (Q20913)
- vision distortion (Q20912)
- blurred vision (Q20911)
- giddiness (Q20910)
- hypoactivity (Q20909)
- hypokinesia (Q20908)
- spasticity (Q20907)
- synucleinopathy (Q20906)
- Parkinson's disease (Q20905)
- psychiatric medication (Q20904)
- mood stabilizer (Q20903)
- tranquilizer (Q20902)
- antipsychotics (Q20901)
- neurotransmitter agent (Q20900)